Novartis explores blockchain’s potential for pharmaceuticals

In large companies business people are approaching IT and saying ‘Hey I have a blockchain idea’. It used to work the other way around, with IT persuading executives to adopt technologies. For Marco Cuomo and Daniel Fritz who support blockchain activities at Novartis, this presents a unique set of challenges and opportunities. So they’ve come up with some novel approaches. The colleagues also shared with Ledger Insights what they’re working on and their views on the evolution of patient control over data.

Demos and an internal blockchain

Novartis has been experimenting with blockchain since 2016 and has run various proofs of concept (PoCs). But for many in the organization some of the ideas are abstract. So they brought a blockchain application to life using IoT and robotics.

Article continues …

---